Jiuzhitang Co., Ltd. (SHE:000989)

Market Cap	8.31B +17.9%
Revenue (ttm)	2.23B -6.0%
Net Income	222.60M +3.0%
EPS	0.26 +3.4%
Shares Out	846.28M
PE Ratio	37.34
Forward PE	n/a
Dividend	0.30 (3.02%)
Ex-Dividend Date	May 8, 2025

Volume	19,573,311
Average Volume	23,489,765
Open	9.87
Previous Close	9.82
Day's Range	9.60 - 9.87
52-Week Range	7.98 - 13.30
Beta	0.34
RSI	55.89
Earnings Date	Aug 24, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,674
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000989

Financial Performance

In 2025, Jiuzhitang's revenue was 2.23 billion, a decrease of -5.99% compared to the previous year's 2.37 billion. Earnings were 222.60 million, an increase of 2.96%.